Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Elicio Therapeutics Inc’s current trading price is 9.58% away from its 52-week high, while its distance from the 52-week low is 218.38%. The stock’s price range over this period has fluctuated between $3.70 and $10.75. The company, operating within the financial sector, had a trading volume of approximately 0.92 million for the day, which was noticeably higher than the average daily share volume of 51370.0 over the last 3 months.
The present stock price for Elicio Therapeutics Inc (ELTX) is $11.78. In the last trading session, the stock made a considerable jump, reaching $13.0 after an opening price of $11.78. The stock briefly fell to $12.0 before ending the session at $9.84.
Elicio Therapeutics Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $10.75 on 08/18/25 and a low of $3.70 for the same time frame on 09/03/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Elicio Therapeutics Inc (ELTX) has experienced a quarterly rise of 121.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 192.47M and boasts a workforce of 32 employees.
Elicio Therapeutics Inc: What Analysts Are Saying
As of right now, 1 analyst is rating Elicio Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.30, with a change in price of +3.47. Similarly, Elicio Therapeutics Inc recorded 55,492 in trading volume during the last 100 days, posting a change of +41.76%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ELTX stands at 8.14. Similarly, the long-term debt-to-equity ratio is also 7.62.
ELTX Stock Stochastic Average
Today, Elicio Therapeutics Inc’s raw stochastic average for the past 50 days stands at 86.83%, indicating a rise from the raw stochastic average of the last 20 days, which was 83.63%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 68.95% and 59.49% respectively.
ELTX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price gain of 160.04% this year. Over the last six months, there has been a weaker performance of 53.19%. The price of ELTX fallen by 26.12% during the last 30 days period. For the last 5-days stocks have improved 36.18%.
